Click on image to view larger version.

Figure 1 The molecular structure of regadenoson (CVT-3146; (1-{9-[(4S, 2R, 3R, 5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2yl]-6aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide).